Level 2 quotes
The level 2 quotes look pretty much the same as yesterday. The large ask of 100,000 shares sits at 0.265. Otherwise no big new bids.
This tells us that the thing that is determining price action right now is NOT clinical data. The clinical data was very good. In any other biotech company the clinical data would cause a price spike.
It's all about the uncertainty of where the next installment of money may come from.
And the fact that the same pool of people cotinue to be the only ones who know anything about this company. No new buyers showing up yet.